125 related articles for article (PubMed ID: 27682966)
21. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
McIntosh J; Sturpe DA; Khanna N
J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
[TBL] [Abstract][Full Text] [Related]
22. [HPV immunization for the prevention of cervical cancer].
Mougin C; Bourgault-Villada I; Coursaget P
Presse Med; 2009 Dec; 38(12):1750-68. PubMed ID: 19765945
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus immunogen that provides protective tumor immunity and induces tumor regression.
Marquez JP; Rivera R; Kang KH; Gardner MB; Torres JV
Viral Immunol; 2012 Apr; 25(2):141-52. PubMed ID: 22486305
[TBL] [Abstract][Full Text] [Related]
24. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
Alani H; Henty JR; Thompson NL; Jury E; Ciurtin C
Scand J Rheumatol; 2018 Mar; 47(2):141-154. PubMed ID: 28927315
[TBL] [Abstract][Full Text] [Related]
25. Season, sun, sex, and cervical cancer.
Hrushesky WJ; Sothern RB; Rietveld WJ; Du Quiton J; Boon ME
Cancer Epidemiol Biomarkers Prev; 2005 Aug; 14(8):1940-7. PubMed ID: 16103441
[TBL] [Abstract][Full Text] [Related]
26. [Human papillomavirus nonavalent vaccine. Update 2017].
Bosch FX; Moreno D; Redondo E; Torné A
Semergen; 2017; 43(4):265-276. PubMed ID: 28549940
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
[TBL] [Abstract][Full Text] [Related]
28. Ten years of HPV vaccines: State of art and controversies.
Angioli R; Lopez S; Aloisi A; Terranova C; De Cicco C; Scaletta G; Capriglione S; Miranda A; Luvero D; Ricciardi R; Montera R; Plotti F
Crit Rev Oncol Hematol; 2016 Jun; 102():65-72. PubMed ID: 27066937
[TBL] [Abstract][Full Text] [Related]
29. Incidence of cervical human papillomavirus infection in systemic lupus erythematosus women.
Mendoza-Pinto C; García-Carrasco M; Vallejo-Ruiz V; Méndez-Martínez S; Taboada-Cole A; Etchegaray-Morales I; Muñóz-Guarneros M; Reyes-Leyva J; López-Colombo A
Lupus; 2017 Aug; 26(9):944-951. PubMed ID: 28059024
[TBL] [Abstract][Full Text] [Related]
30. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
McCormack PL; Joura EA
BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
[TBL] [Abstract][Full Text] [Related]
31. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.
; Romanowski B; de Borba PC; Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; Aoki F; Ramjattan B; Shier RM; Somani R; Barbier S; Blatter MM; Chambers C; Ferris D; Gall SA; Guerra FA; Harper DM; Hedrick JA; Henry DC; Korn AP; Kroll R; Moscicki AB; Rosenfeld WD; Sullivan BJ; Thoming CS; Tyring SK; Wheeler CM; Dubin G; Schuind A; Zahaf T; Greenacre M; Sgriobhadair A
Lancet; 2009 Dec; 374(9706):1975-85. PubMed ID: 19962185
[TBL] [Abstract][Full Text] [Related]
32. Cervical adenocarcinoma: moving towards better prevention.
Seoud M; Tjalma WA; Ronsse V
Vaccine; 2011 Nov; 29(49):9148-58. PubMed ID: 21983356
[TBL] [Abstract][Full Text] [Related]
33. Conceptual, statistical and clinical interpretation of results from a systematic review and meta-analysis of prevalence of cervical HPV infection in women with SLE.
Jayaraj R; Kumarasamy C
Autoimmun Rev; 2019 Apr; 18(4):433-434. PubMed ID: 30763632
[No Abstract] [Full Text] [Related]
34. Prevalence of cutaneous warts in patients with systemic lupus erythematosus: a systematic review.
Silva LM; Santos WG; Santiago MB
J Infect Dev Ctries; 2016 Sep; 10(9):902-906. PubMed ID: 27694721
[TBL] [Abstract][Full Text] [Related]
35. Risk of rheumatic disease in breast implant users: a qualitative systematic review.
Hoa S; Milord K; Hudson M; Nicolaidis SC; Bourré-Tessier J
Gland Surg; 2021 Aug; 10(8):2557-2576. PubMed ID: 34527567
[TBL] [Abstract][Full Text] [Related]
36. Human Papiloma Virus Screening: Evaluation Of Testing And Surveillance In Rheumatoid Arthritis, Psoriatic Arthritis And Systemic Lupus Erythematosus.
Vidal Alejandre B; Tovar Sugrañes E; López Poza R; Andrés M; Martínez-Vidal MP
Reumatol Clin (Engl Ed); 2020 Jul; ():. PubMed ID: 32709510
[TBL] [Abstract][Full Text] [Related]
37. Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
Goulenok T; Mendes C; Dayan L; Ferre VM; Bucau M; Farhi F; Papo T; Sacré K
J Rheumatol; 2023 Jun; ():. PubMed ID: 37263652
[TBL] [Abstract][Full Text] [Related]
38. Corrigendum to 'Prevalence of cervical HPV infection in women with systemic lupus erythematosus: a systematic review and meta-analysis'. [AUTREV 18-2 (2019) 184-191].
García-Carrasco M; Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Vallejo-Ruiz V; Munguía-Realpozo P; Colombo AL; Cervera R
Autoimmun Rev; 2019 Apr; 18(4):437. PubMed ID: 30770318
[No Abstract] [Full Text] [Related]
39. Population-Based Incidence Rates of Cervical Intraepithelial Neoplasia in the Human Papillomavirus Vaccine Era.
Benard VB; Castle PE; Jenison SA; Hunt WC; Kim JJ; Cuzick J; Lee JH; Du R; Robertson M; Norville S; Wheeler CM;
JAMA Oncol; 2017 Jun; 3(6):833-837. PubMed ID: 27685805
[TBL] [Abstract][Full Text] [Related]
40. HPV Vaccination: Attitude and Knowledge among German Gynecologists.
Kolben TM; Dannecker C; Baltateanu K; Goess C; Starrach T; Semmlinger A; Ditsch N; Gallwas J; Mahner S; Friese K; Kolben T
Geburtshilfe Frauenheilkd; 2016 Oct; 76(10):1074-1080. PubMed ID: 27761028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
